APO Research
Talk to an analyst

APO RESEARCH · REPORT

SARS-Cov-2 Vaccine (Vero Cell)

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global SARS-Cov-2 Vaccine (Vero Cell) Industry Growth and Trends Forecast to 2032

29 December 202591 pages

Choose your research edition.

Industry ResearchSARS-Cov-2 Vaccine (Vero Cell) Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal SARS-Cov-2 Vaccine (Vero Cell) Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal SARS-Cov-2 Vaccine (Vero Cell) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal SARS-Cov-2 Vaccine (Vero Cell) Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal SARS-Cov-2 Vaccine (Vero Cell) Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global SARS-Cov-2 Vaccine (Vero Cell) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for SARS-Cov-2 Vaccine (Vero Cell) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for SARS-Cov-2 Vaccine (Vero Cell) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for SARS-Cov-2 Vaccine (Vero Cell) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of SARS-Cov-2 Vaccine (Vero Cell) include Sinopharm, Pfizer, WIBP, Sinovac Biotech, IMBCAMS,China and BIBP, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global SARS-Cov-2 Vaccine (Vero Cell) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The SARS-Cov-2 Vaccine (Vero Cell) market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global SARS-Cov-2 Vaccine (Vero Cell) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to SARS-Cov-2 Vaccine (Vero Cell).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global SARS-Cov-2 Vaccine (Vero Cell) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

SARS-Cov-2 Vaccine (Vero Cell) Market by Company

Sinopharm

Pfizer

WIBP

Sinovac Biotech

IMBCAMS,China

BIBP

SARS-Cov-2 Vaccine (Vero Cell) Segment by Type

Subunit Vaccine

Whole Virus Inactivated Vaccine

Split Vaccine

Others

SARS-Cov-2 Vaccine (Vero Cell) Segment by Application

Special Population

General Population

SARS-Cov-2 Vaccine (Vero Cell) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global SARS-Cov-2 Vaccine (Vero Cell) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of SARS-Cov-2 Vaccine (Vero Cell) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of SARS-Cov-2 Vaccine (Vero Cell).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of SARS-Cov-2 Vaccine (Vero Cell) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of SARS-Cov-2 Vaccine (Vero Cell) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Subunit Vaccine Table 2. Major Company of Whole Virus Inactivated Vaccine Table 3. Major Company of Split Vaccine Table 4. Major Company of Others Table 5. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2021-2026) & (K Units) Table 7. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share in Volume by Type (2021-2026) Table 8. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2021-2026) & (US$ Million) Table 9. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share in Value by Type (2021-2026) Table 10. Global SARS-Cov-2 Vaccine (Vero Cell) Price by Type (2021-2026) & (US$/Unit) Table 11. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2027-2032) & (K Units) Table 12. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share in Volume by Type (2027-2032) Table 13. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2027-2032) & (US$ Million) Table 14. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share in Value by Type (2027-2032) Table 15. Global SARS-Cov-2 Vaccine (Vero Cell) Price by Type (2027-2032) & (US$/Unit) Table 16. North America SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2021-2026) & (K Units) Table 17. North America SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2021-2026) & (US$ Million) Table 18. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2021-2026) & (K Units) Table 19. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2021-2026) & (K Units) Table 23. Latin America SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2021-2026) & (US$ Million) Table 26. SARS-Cov-2 Vaccine (Vero Cell) Industry Trends Table 27. SARS-Cov-2 Vaccine (Vero Cell) Industry Drivers Table 28. SARS-Cov-2 Vaccine (Vero Cell) Industry Opportunities and Challenges Table 29. SARS-Cov-2 Vaccine (Vero Cell) Industry Restraints Table 30. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Company (2021-2026) Table 32. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Company (2021-2026) & (K Units) Table 33. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Share by Company (2021-2026) Table 34. Global SARS-Cov-2 Vaccine (Vero Cell) Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global SARS-Cov-2 Vaccine (Vero Cell) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global SARS-Cov-2 Vaccine (Vero Cell) Major Company Production Sites and Headquarters Table 37. Global SARS-Cov-2 Vaccine (Vero Cell) Company, Product Type & Application Table 38. Global SARS-Cov-2 Vaccine (Vero Cell) Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global SARS-Cov-2 Vaccine (Vero Cell) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global SARS-Cov-2 Vaccine (Vero Cell) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Region (2021-2026) & (K Units) Table 43. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share in Volume by Region (2021-2026) Table 44. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Region (2021-2026) & (US$ Million) Table 45. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share in Value by Region (2021-2026) Table 46. Global SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Region (2027-2032) & (K Units) Table 48. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share in Volume by Region (2027-2032) Table 49. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Region (2027-2032) & (US$ Million) Table 50. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share in Value by Region (2027-2032) Table 51. Global SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2021-2026) & (K Units) Table 54. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share in Volume by Application (2021-2026) Table 55. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2021-2026) & (US$ Million) Table 56. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share in Value by Application (2021-2026) Table 57. Global SARS-Cov-2 Vaccine (Vero Cell) Price by Application (2021-2026) & (US$/Unit) Table 58. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2027-2032) & (K Units) Table 59. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share in Volume by Application (2027-2032) Table 60. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2027-2032) & (US$ Million) Table 61. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share in Value by Application (2027-2032) Table 62. Global SARS-Cov-2 Vaccine (Vero Cell) Price by Application (2027-2032) & (US$/Unit) Table 63. North America SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2021-2026) & (K Units) Table 64. North America SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2021-2026) & (US$ Million) Table 65. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2021-2026) & (K Units) Table 66. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2021-2026) & (K Units) Table 70. Latin America SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2021-2026) & (US$ Million) Table 73. Sinopharm Company Information Table 74. Sinopharm Business Overview Table 75. Sinopharm SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Sinopharm SARS-Cov-2 Vaccine (Vero Cell) Product Portfolio Table 77. Sinopharm Recent Development Table 78. Pfizer Company Information Table 79. Pfizer Business Overview Table 80. Pfizer SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Pfizer SARS-Cov-2 Vaccine (Vero Cell) Product Portfolio Table 82. Pfizer Recent Development Table 83. WIBP Company Information Table 84. WIBP Business Overview Table 85. WIBP SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. WIBP SARS-Cov-2 Vaccine (Vero Cell) Product Portfolio Table 87. WIBP Recent Development Table 88. Sinovac Biotech Company Information Table 89. Sinovac Biotech Business Overview Table 90. Sinovac Biotech SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Sinovac Biotech SARS-Cov-2 Vaccine (Vero Cell) Product Portfolio Table 92. Sinovac Biotech Recent Development Table 93. IMBCAMS,China Company Information Table 94. IMBCAMS,China Business Overview Table 95. IMBCAMS,China SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. IMBCAMS,China SARS-Cov-2 Vaccine (Vero Cell) Product Portfolio Table 97. IMBCAMS,China Recent Development Table 98. BIBP Company Information Table 99. BIBP Business Overview Table 100. BIBP SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. BIBP SARS-Cov-2 Vaccine (Vero Cell) Product Portfolio Table 102. BIBP Recent Development Table 103. North America SARS-Cov-2 Vaccine (Vero Cell) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 104. North America SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2021-2026) & (K Units) Table 105. North America SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Country (2021-2026) Table 106. North America SARS-Cov-2 Vaccine (Vero Cell) Sales Forecast by Country (2027-2032) & (K Units) Table 107. North America SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share Forecast by Country (2027-2032) Table 108. North America SARS-Cov-2 Vaccine (Vero Cell) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. North America SARS-Cov-2 Vaccine (Vero Cell) Market Size by Country (2021-2026) & (US$ Million) Table 110. North America SARS-Cov-2 Vaccine (Vero Cell) Market Share by Country (2021-2026) Table 111. North America SARS-Cov-2 Vaccine (Vero Cell) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. North America SARS-Cov-2 Vaccine (Vero Cell) Market Share Forecast by Country (2027-2032) Table 113. Europe SARS-Cov-2 Vaccine (Vero Cell) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 114. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2021-2026) & (K Units) Table 115. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Country (2021-2026) Table 116. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Forecast by Country (2027-2032) & (K Units) Table 117. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share Forecast by Country (2027-2032) Table 118. Europe SARS-Cov-2 Vaccine (Vero Cell) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Europe SARS-Cov-2 Vaccine (Vero Cell) Market Size by Country (2021-2026) & (US$ Million) Table 120. Europe SARS-Cov-2 Vaccine (Vero Cell) Market Share by Country (2021-2026) Table 121. Europe SARS-Cov-2 Vaccine (Vero Cell) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Europe SARS-Cov-2 Vaccine (Vero Cell) Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific SARS-Cov-2 Vaccine (Vero Cell) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2021-2026) & (K Units) Table 125. Asia-Pacific SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Country (2021-2026) Table 126. Asia-Pacific SARS-Cov-2 Vaccine (Vero Cell) Sales Forecast by Country (2027-2032) & (K Units) Table 127. Asia-Pacific SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific SARS-Cov-2 Vaccine (Vero Cell) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific SARS-Cov-2 Vaccine (Vero Cell) Market Size by Country (2021-2026) & (US$ Million) Table 130. Asia-Pacific SARS-Cov-2 Vaccine (Vero Cell) Market Share by Country (2021-2026) Table 131. Asia-Pacific SARS-Cov-2 Vaccine (Vero Cell) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Asia-Pacific SARS-Cov-2 Vaccine (Vero Cell) Market Share Forecast by Country (2027-2032) Table 133. Latin America SARS-Cov-2 Vaccine (Vero Cell) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 134. Latin America SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2021-2026) & (K Units) Table 135. Latin America SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Country (2021-2026) Table 136. Latin America SARS-Cov-2 Vaccine (Vero Cell) Sales Forecast by Country (2027-2032) & (K Units) Table 137. Latin America SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share Forecast by Country (2027-2032) Table 138. Latin America SARS-Cov-2 Vaccine (Vero Cell) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America SARS-Cov-2 Vaccine (Vero Cell) Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America SARS-Cov-2 Vaccine (Vero Cell) Market Share by Country (2021-2026) Table 141. Latin America SARS-Cov-2 Vaccine (Vero Cell) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America SARS-Cov-2 Vaccine (Vero Cell) Market Share Forecast by Country (2027-2032) Table 143. Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 144. Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2021-2026) & (K Units) Table 145. Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Country (2021-2026) Table 146. Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Sales Forecast by Country (2027-2032) & (K Units) Table 147. Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share Forecast by Country (2027-2032) Table 148. Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Market Size by Country (2021-2026) & (US$ Million) Table 150. Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Market Share by Country (2021-2026) Table 151. Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Market Share Forecast by Country (2027-2032) Table 153. Key Raw Materials Table 154. Raw Materials Key Suppliers Table 155. SARS-Cov-2 Vaccine (Vero Cell) Distributors List Table 156. SARS-Cov-2 Vaccine (Vero Cell) Customers List Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. SARS-Cov-2 Vaccine (Vero Cell) Image Figure 2. Global SARS-Cov-2 Vaccine (Vero Cell) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global SARS-Cov-2 Vaccine (Vero Cell) Market Size (2021-2032) & (US$ Million) Figure 4. Global SARS-Cov-2 Vaccine (Vero Cell) Sales (2021-2032) & (K Units) Figure 5. Subunit Vaccine Image Figure 6. Global Subunit Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 7. Whole Virus Inactivated Vaccine Image Figure 8. Global Whole Virus Inactivated Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 9. Split Vaccine Image Figure 10. Global Split Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global SARS-Cov-2 Vaccine (Vero Cell) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global SARS-Cov-2 Vaccine (Vero Cell) Market Share by Type 2025 VS 2032 Figure 15. North America SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share in Volume by Type in 2025 Figure 16. North America SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share in Value by Type in 2025 Figure 17. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share in Volume by Type in 2025 Figure 18. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share in Value by Type in 2025 Figure 21. Latin America SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share in Volume by Type in 2025 Figure 22. Latin America SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 SARS-Cov-2 Vaccine (Vero Cell) Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Special Population Image Figure 28. Global Special Population Sales YoY Growth (2021-2032) & (K Units) Figure 29. General Population Image Figure 30. Global General Population Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global SARS-Cov-2 Vaccine (Vero Cell) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global SARS-Cov-2 Vaccine (Vero Cell) Market Share by Application 2025 VS 2032 Figure 33. North America SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share in Volume by Application in 2025 Figure 34. North America SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share in Value by Application in 2025 Figure 35. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share in Volume by Application in 2025 Figure 36. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share in Value by Application in 2025 Figure 39. Latin America SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share in Volume by Application in 2025 Figure 40. Latin America SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share in Value by Application in 2025 Figure 43. North America SARS-Cov-2 Vaccine (Vero Cell) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America SARS-Cov-2 Vaccine (Vero Cell) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America SARS-Cov-2 Vaccine (Vero Cell) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America SARS-Cov-2 Vaccine (Vero Cell) Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe SARS-Cov-2 Vaccine (Vero Cell) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe SARS-Cov-2 Vaccine (Vero Cell) Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific SARS-Cov-2 Vaccine (Vero Cell) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific SARS-Cov-2 Vaccine (Vero Cell) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific SARS-Cov-2 Vaccine (Vero Cell) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific SARS-Cov-2 Vaccine (Vero Cell) Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America SARS-Cov-2 Vaccine (Vero Cell) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America SARS-Cov-2 Vaccine (Vero Cell) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America SARS-Cov-2 Vaccine (Vero Cell) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America SARS-Cov-2 Vaccine (Vero Cell) Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. SARS-Cov-2 Vaccine (Vero Cell) Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. SARS-Cov-2 Vaccine (Vero Cell) Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Subunit Vaccine
  • Whole Virus Inactivated Vaccine
  • Split Vaccine
  • Others
Applications
  • Special Population
  • General Population
Companies covered
  • Sinopharm
  • Pfizer
  • WIBP
  • Sinovac Biotech
  • IMBCAMS,China
  • BIBP

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global SARS-Cov-2 Vaccine (Vero Cell) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global SARS-Cov-2 Vaccine (Vero Cell) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 SARS-Cov-2 Vaccine (Vero Cell) Market by Type
  6. 1.3.1 Subunit Vaccine
  7. 1.3.2 Whole Virus Inactivated Vaccine
  8. 1.3.3 Split Vaccine
  9. 1.3.4 Others
  10. 1.4 Global SARS-Cov-2 Vaccine (Vero Cell) Market Size by Type
  11. 1.4.1 Global SARS-Cov-2 Vaccine (Vero Cell) Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global SARS-Cov-2 Vaccine (Vero Cell) Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global SARS-Cov-2 Vaccine (Vero Cell) Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America SARS-Cov-2 Vaccine (Vero Cell) Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific SARS-Cov-2 Vaccine (Vero Cell) Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America SARS-Cov-2 Vaccine (Vero Cell) Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 SARS-Cov-2 Vaccine (Vero Cell) Industry Trends
  2. 2.2 SARS-Cov-2 Vaccine (Vero Cell) Industry Drivers
  3. 2.3 SARS-Cov-2 Vaccine (Vero Cell) Industry Opportunities and Challenges
  4. 2.4 SARS-Cov-2 Vaccine (Vero Cell) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by SARS-Cov-2 Vaccine (Vero Cell) Revenue (2021-2026)
  2. 3.2 Global Top Players by SARS-Cov-2 Vaccine (Vero Cell) Sales (2021-2026)
  3. 3.3 Global Top Players by SARS-Cov-2 Vaccine (Vero Cell) Price (2021-2026)
  4. 3.4 Global SARS-Cov-2 Vaccine (Vero Cell) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global SARS-Cov-2 Vaccine (Vero Cell) Major Company Production Sites & Headquarters
  6. 3.6 Global SARS-Cov-2 Vaccine (Vero Cell) Company, Product Type & Application
  7. 3.7 Global SARS-Cov-2 Vaccine (Vero Cell) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global SARS-Cov-2 Vaccine (Vero Cell) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 SARS-Cov-2 Vaccine (Vero Cell) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 SARS-Cov-2 Vaccine (Vero Cell) Tier 1, Tier 2, and Tier 3
4 SARS-Cov-2 Vaccine (Vero Cell) Regional Status and Outlook
  1. 4.1 Global SARS-Cov-2 Vaccine (Vero Cell) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global SARS-Cov-2 Vaccine (Vero Cell) Historic Market Size by Region
  3. 4.2.1 Global SARS-Cov-2 Vaccine (Vero Cell) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global SARS-Cov-2 Vaccine (Vero Cell) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global SARS-Cov-2 Vaccine (Vero Cell) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global SARS-Cov-2 Vaccine (Vero Cell) Forecasted Market Size by Region
  7. 4.3.1 Global SARS-Cov-2 Vaccine (Vero Cell) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global SARS-Cov-2 Vaccine (Vero Cell) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global SARS-Cov-2 Vaccine (Vero Cell) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 SARS-Cov-2 Vaccine (Vero Cell) by Application
  1. 5.1 SARS-Cov-2 Vaccine (Vero Cell) Market by Application
  2. 5.1.1 Special Population
  3. 5.1.2 General Population
  4. 5.2 Global SARS-Cov-2 Vaccine (Vero Cell) Market Size by Application
  5. 5.2.1 Global SARS-Cov-2 Vaccine (Vero Cell) Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global SARS-Cov-2 Vaccine (Vero Cell) Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global SARS-Cov-2 Vaccine (Vero Cell) Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America SARS-Cov-2 Vaccine (Vero Cell) Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific SARS-Cov-2 Vaccine (Vero Cell) Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America SARS-Cov-2 Vaccine (Vero Cell) Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sinopharm
  2. 6.1.1 Sinopharm Company Information
  3. 6.1.2 Sinopharm Business Overview
  4. 6.1.3 Sinopharm SARS-Cov-2 Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sinopharm SARS-Cov-2 Vaccine (Vero Cell) Product Portfolio
  6. 6.1.5 Sinopharm Recent Developments
  7. 6.2 Pfizer
  8. 6.2.1 Pfizer Company Information
  9. 6.2.2 Pfizer Business Overview
  10. 6.2.3 Pfizer SARS-Cov-2 Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Pfizer SARS-Cov-2 Vaccine (Vero Cell) Product Portfolio
  12. 6.2.5 Pfizer Recent Developments
  13. 6.3 WIBP
  14. 6.3.1 WIBP Company Information
  15. 6.3.2 WIBP Business Overview
  16. 6.3.3 WIBP SARS-Cov-2 Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 WIBP SARS-Cov-2 Vaccine (Vero Cell) Product Portfolio
  18. 6.3.5 WIBP Recent Developments
  19. 6.4 Sinovac Biotech
  20. 6.4.1 Sinovac Biotech Company Information
  21. 6.4.2 Sinovac Biotech Business Overview
  22. 6.4.3 Sinovac Biotech SARS-Cov-2 Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sinovac Biotech SARS-Cov-2 Vaccine (Vero Cell) Product Portfolio
  24. 6.4.5 Sinovac Biotech Recent Developments
  25. 6.5 IMBCAMS,China
  26. 6.5.1 IMBCAMS,China Company Information
  27. 6.5.2 IMBCAMS,China Business Overview
  28. 6.5.3 IMBCAMS,China SARS-Cov-2 Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 IMBCAMS,China SARS-Cov-2 Vaccine (Vero Cell) Product Portfolio
  30. 6.5.5 IMBCAMS,China Recent Developments
  31. 6.6 BIBP
  32. 6.6.1 BIBP Company Information
  33. 6.6.2 BIBP Business Overview
  34. 6.6.3 BIBP SARS-Cov-2 Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 BIBP SARS-Cov-2 Vaccine (Vero Cell) Product Portfolio
  36. 6.6.5 BIBP Recent Developments
7 North America by Country
  1. 7.1 North America SARS-Cov-2 Vaccine (Vero Cell) Sales by Country
  2. 7.1.1 North America SARS-Cov-2 Vaccine (Vero Cell) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2021-2026)
  4. 7.1.3 North America SARS-Cov-2 Vaccine (Vero Cell) Sales Forecast by Country (2027-2032)
  5. 7.2 North America SARS-Cov-2 Vaccine (Vero Cell) Market Size by Country
  6. 7.2.1 North America SARS-Cov-2 Vaccine (Vero Cell) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America SARS-Cov-2 Vaccine (Vero Cell) Market Size by Country (2021-2026)
  8. 7.2.3 North America SARS-Cov-2 Vaccine (Vero Cell) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Country
  2. 8.1.1 Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2021-2026)
  4. 8.1.3 Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe SARS-Cov-2 Vaccine (Vero Cell) Market Size by Country
  6. 8.2.1 Europe SARS-Cov-2 Vaccine (Vero Cell) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe SARS-Cov-2 Vaccine (Vero Cell) Market Size by Country (2021-2026)
  8. 8.2.3 Europe SARS-Cov-2 Vaccine (Vero Cell) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific SARS-Cov-2 Vaccine (Vero Cell) Sales by Country
  2. 9.1.1 Asia-Pacific SARS-Cov-2 Vaccine (Vero Cell) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific SARS-Cov-2 Vaccine (Vero Cell) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific SARS-Cov-2 Vaccine (Vero Cell) Market Size by Country
  6. 9.2.1 Asia-Pacific SARS-Cov-2 Vaccine (Vero Cell) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific SARS-Cov-2 Vaccine (Vero Cell) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific SARS-Cov-2 Vaccine (Vero Cell) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America SARS-Cov-2 Vaccine (Vero Cell) Sales by Country
  2. 10.1.1 South America SARS-Cov-2 Vaccine (Vero Cell) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2021-2026)
  4. 10.1.3 South America SARS-Cov-2 Vaccine (Vero Cell) Sales Forecast by Country (2027-2032)
  5. 10.2 South America SARS-Cov-2 Vaccine (Vero Cell) Market Size by Country
  6. 10.2.1 South America SARS-Cov-2 Vaccine (Vero Cell) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America SARS-Cov-2 Vaccine (Vero Cell) Market Size by Country (2021-2026)
  8. 10.2.3 South America SARS-Cov-2 Vaccine (Vero Cell) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Sales by Country
  2. 11.1.1 Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Market Size by Country
  6. 11.2.1 Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 SARS-Cov-2 Vaccine (Vero Cell) Value Chain Analysis
  2. 12.1.1 SARS-Cov-2 Vaccine (Vero Cell) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 SARS-Cov-2 Vaccine (Vero Cell) Production Mode & Process
  7. 12.2 SARS-Cov-2 Vaccine (Vero Cell) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 SARS-Cov-2 Vaccine (Vero Cell) Distributors
  10. 12.2.3 SARS-Cov-2 Vaccine (Vero Cell) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst